Literature DB >> 8445034

11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.

P M Stewart1, P Burra, C H Shackleton, M C Sheppard, E Elias.   

Abstract

11 beta-Hydroxysteroid dehydrogenase (11 beta HSD), found predominantly in liver and kidney, is responsible for the shuttling of active cortisol to cortisone. A defect in this shuttle mechanism, e.g. after liquorice ingestion, results in an increase in the ratio of urinary cortisol [tetrahydrocortisol (THF)] to cortisone [tetrahydrocortisone (THE)] metabolites. The plasma cortisol half-life is prolonged, but concentrations remain normal because of a concomitant fall in cortisol production. Alcohol-induced pseudo-Cushing's syndrome is an ill defined cause of Cushing's syndrome. Because many of the documented cases have abnormal liver function tests, we have investigated whether abnormal hepatic 11 beta HSD activity may play a role in the pathogenesis of the condition. Fourteen patients with alcoholic (ALD) and 14 patients with non-alcoholic (CLD) chronic liver disease had marked deficiency of 11 beta HSD [5 alpha-THF + THF/THE: ALD, 1.94 +/- 0.38 (+/- SEM); CLD, 1.82 +/- 0.20] compared to controls (0.94 +/- 0.04; P < 0.01 and 0.001, respectively). In the CLD group, the daily cortisol production rate (as assessed by summation of principal cortisol metabolites) was reduced appropriately [median, 3,510; range, 1,101-8,940 micrograms/24 h; controls, 5,492 (range, 3,818-14,996) micrograms/24 h; P < 0.001], and normal 0900 h plasma cortisol and urinary free cortisol levels were maintained. However, in the ALD group, there was no concomitant fall in the cortisol production rate (sum of cortisol metabolites, 5,043 micrograms/24 h; range, 520-27,344). As a consequence, 0900 h plasma cortisol in the ALD group was significantly elevated (633 +/- 52 nmol/L) compared to values in the CLD group (487 +/- 48 nmol/L; P < 0.05) and controls (432 +/- 27 nmol/L; P < 0.001). Our findings of glucocorticoid excess in patients with chronic ALD may indicate that alcohol-induced pseudo-Cushing's syndrome develops as a result of continuing normal cortisol secretion in the face of impaired cortisol metabolism. The latter is mediated by defective hepatic 11 beta HSD activity; the former by either abnormal glucocorticoid feedback or stimulation of cortisol secretion at the level of the hypothalamus/pituitary.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445034     DOI: 10.1210/jcem.76.3.8445034

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

2.  Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.

Authors:  Roland H Stimson; Jonas Andersson; Ruth Andrew; Doris N Redhead; Fredrik Karpe; Peter C Hayes; Tommy Olsson; Brian R Walker
Journal:  Diabetes       Date:  2008-10-13       Impact factor: 9.461

3.  Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice.

Authors:  Alison D McNeilly; David P Macfarlane; Emmett O'Flaherty; Dawn E Livingstone; Tijana Mitić; Kirsty M McConnell; Scott M McKenzie; Eleanor Davies; Rebecca M Reynolds; Helle C Thiesson; Ole Skøtt; Brian R Walker; Ruth Andrew
Journal:  J Hepatol       Date:  2010-03-04       Impact factor: 25.083

4.  Increased plasma corticosterone contributes to the development of alcoholic fatty liver in mice.

Authors:  Xiuhua Sun; Weijun Luo; Xiaobing Tan; Qiong Li; Yantao Zhao; Wei Zhong; Xinguo Sun; Cory Brouwer; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-10       Impact factor: 4.052

Review 5.  Adrenal Insufficiency in Cirrhosis.

Authors:  Brian J Wentworth; Helmy M Siragy
Journal:  J Endocr Soc       Date:  2022-07-29

6.  Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome.

Authors:  Ahmad Moolla; Jasper de Boer; David Pavlov; Amin Amin; Angela Taylor; Lorna Gilligan; Beverly Hughes; John Ryan; Eleanor Barnes; Zaki Hassan-Smith; Jane Grove; Guruprasad P Aithal; An Verrijken; Sven Francque; Luc Van Gaal; Matthew J Armstrong; Phillip N Newsome; Jeremy F Cobbold; Wiebke Arlt; Michael Biehl; Jeremy W Tomlinson
Journal:  Aliment Pharmacol Ther       Date:  2020-04-16       Impact factor: 9.524

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.